Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 23;32(1):e100054.
doi: 10.1136/gpsych-2019-100054. eCollection 2019.

Biomarkers for the diagnosis of Alzheimer's disease, dementia Lewy body, frontotemporal dementia and vascular dementia

Joshua Marvin Anthony Maclin  1   2   3 , Tao Wang  2   3 , Shifu Xiao  2   3
Affiliations

Biomarkers for the diagnosis of Alzheimer's disease, dementia Lewy body, frontotemporal dementia and vascular dementia

Joshua Marvin Anthony Maclin et al. Gen Psychiatr. .

Abstract

Background: Dementia is a chronic brain disorder classified by four distinct diseases that impact cognition and mental degeneration. Each subgroup exhibits similar brain deficiencies and mutations. This review will focus on four dementia subgroups: Alzheimer's disease, vascular dementia, frontotemporal dementia and dementia Lewy body.

Aim: The aim of this systematic review is to create a concise overview of unique similarities within dementia used to locate and identify new biomarker methods in diagnosing dementia.

Methods: 123 300 articles published after 2010 were identified from PubMed, JSTOR, WorldCat Online Computer Library and PALNI (Private Academic Library Network of Indiana) using the following search items (in title or abstract): 'Neurodegenerative Diseases' OR 'Biomarkers' OR 'Alzheimer's Disease' OR 'Frontal Temporal Lobe Dementia' OR 'Vascular Dementia' OR 'Dementia Lewy Body' OR 'Cerebral Spinal Fluid' OR 'Mental Cognitive Impairment'. 47 studies were included in the qualitative synthesis.

Results: Evidence suggested neuroimaging with amyloid positron emission tomography (PET) scanning and newly found PET tracers to be more effective in diagnosing Alzheimer's and amnesiac mental cognitive impairment than carbon-11 Pittsburgh compound-B radioisotope tracer. Newly created methods to make PET scans more accurate and practical in clinical settings signify a major shift in diagnosing dementia and neurodegenerative diseases.

Conclusion: Vast improvements in neuroimaging techniques have led to newly discovered biomarkers and diagnostics. Neuroimaging with amyloid PET scanning surpasses what had been considered the dominant method of neuroimaging and MRI. Newly created methods to make PET scans more accurate and practical in clinical settings signify a major shift in diagnosing dementia pathology. Continued research and studies must be conducted to improve current findings and streamline methods to further subcategorise neurodegenerative disorders and diagnosis.

Keywords: alzheimer’s disease; biomarkers; cerebral spinal fluid; dementia; frontal temporal lobe dementia; mental cognitive impairment; neurodegenerative diseases; vascular dementia.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flowchart of collecting and evaluating research used in this review. PALNI, Private Academic Library Network of Indiana.
See this image and copyright information in PMC

References

    1. Mayeux R. Biomarkers: potential uses and limitations. NeuroRx 2004;1:182–8. 10.1602/neurorx.1.2.182 - DOI - PMC - PubMed
    1. Menéndez-González M. Biomarkers in neurodegenerative disorders: translating research into clinical practice. Frontiers in Aging Neuroscience 2014;6. - PMC - PubMed
    1. Naylor S. Biomarkers: current perspectives and future prospects. Expert Review of Molecular Diagnostics 2003;3:525–9. 10.1586/14737159.3.5.525 - DOI - PubMed
    1. Janssens J, Vermeiren Y, Fransen E, et al. . Cerebrospinal fluid and serum MHPG improve Alzheimer’s disease versus dementia with Lewy bodies differential diagnosis. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2018;10:172–81. - PMC - PubMed
    1. Menéndez-González M. Routine lumbar puncture for the early diagnosis of Alzheimer’s disease. Is it safe? Frontiers in Aging Neuroscience 2014;6. - PMC - PubMed

Publication types

LinkOut - more resources